Antigens of cultured Sarcocystis neurona merozoites were examined using immunoblot analysis. Blotted proteins were probed with S. cruzi, S. muris, and S. neurona antisera produced in rabbits, S. fayeri (pre-and post-infection) and S. neurona (pre-and post-inoculation) sera produced in horses, immune sera from 7 histologically confirmed cases of equine protozoa1 myeloencephalitis (EPM), and pre-suckle serum from a newborn foal. Eight proteins, 70, 24, 23.5, 22.5, 13, 11, 10.5, and 10 Kd, were detected only by S. neurona antiserum and/or immune serum from EPM-affected horses. Equine sera were titered by the indirect immunofluorescent antibody (IFA) method using air-dried, cultured S. neurona merozoites. Anti-Sarcocystis IFA titers were found in horses with or without EPM. Serum titers did not correspond to the number of specific bands recognized on immunoblots.
Equine protozoa1 myeloencephalitis (EPM) is an often debilitating central nervous system (CNS) disease of the horse. 9 It has been reported in horses native to North, 5 South, 1 and Central America. 6 The etiologic agent of EPM was recently cultured from naturally occurring cases in the US 2,3 and Panama 6 
and named

Sarcocystis neurona.
Serological diagnosis of EPM caused by S. neurona has been complicated by the fact that species within the genus Sarcocystis share antigens. 4 For this reason, cross-reactions are observed when antigen from one species is recognized by serum antibody developed polyacrylamide gel electrophoresis (SDS-PAGE) in 0.75 mm, vertical, 5-20% or 10-20% linear gradient polyacrylamide resolving gels and 4% stacking gels using a discontinuous buffer method 8 and silver stained. 7 High-and low-range molecular weight markers were included in separate lanes. b Immunoblots were prepared using 1 x 10 7 solubilized merozoites separated in 1 -well SDS-PAGE gels. Separated proteins were electrophoretically transferred to 0.45 µm nitrocellulose in Towbin buffer (0.192 M glycine, 0.025 M tris pH 8.3, 20% v/v methanol) using 1.0 A constant current for 1 hr. Prestained molecular weight markers were used in a separate lane. c Blotting efficiency was demonstrated by India ink staining of the blot and Coomassie blue staining of the against another species. The objective of this study was transferred gel. 7 Blots were blocked with 5% non-fat dry milk, to identify S. neurona-specific proteins for antemortem 0.1% nonionic emulsifier, d and 0.1% sodium azide in 0.01 diagnostic use that would not cross-react with antibody M PBS, pH 7.2 for 1 hr and subdivided into lanes using a against other species. molded plexiglass press. e Each of the following sera were diluted in blocking buffer and incubated for 2 hr in individual 
Results
Silver staining detected 104 proteins ranging in size from 14 to 300 Kd (Fig. 1) . Although many proteins were recognized on immunoblots by most sera, 8 proteins were detected by sera from EPM-affected or S. neurona -inoculated horses that were not recognized by pre-or post-infection sera from the S. fayeri-infected pony or pre-inoculation serum from the S. neuronainoculated horse ( Table 1) . Six of these also were recognized by rabbit anti-S. neurona serum but not by rabbit anti-S. cruzi or S. muris sera ( Table 1) . Presuckle foal serum detected no proteins (data not shown). Normal rabbit serum reacted with 3 bands common to many of the sera. India ink staining demonstrated successful transfer of proteins to the nitrocellulose.
Immunofluorescent antibody titers are listed in Table 1. Titers below 25 were considered negative based on previous tests of sera from horses without neurologic signs. Rabbit antisera were not tested.
Discussion
Immunoblot and IFA results indicated that the hors- were not related to the number of specific proteins recognized on immunoblots. Two of the horses that recognized all 8 specific proteins had low IFA titers. The chronology of the disease, i.e., sporocyst dose, length of exposure, dissemination of merozites, and treatment regimen, among EPM-affected horses might have affected results. Some of the proteins recognized by sera from cultured merozoites might have been associated with late schizogonous generations that were present only during the chronic phase of natural infection. Paired or sequential serum samples were not available for evaluation. were S. neurona-specific. If the S. fayeri-infected pony or S. neurona-inoculated horse were exposed previously to S. neurona, additional specific proteins might have been undetected. As indicated in Tables 1 and 3 , S. neurona-specific proteins, 22.5, 13, and 10.5 Kd, were recognized by all 7 horses with EPM and the S. neurona -inoculated horse. These proteins should be especially useful for antemortem detection of S. neurona exposure among clinical cases and to determine the seroprevalance of specific antibodies among groups of horses and other animals. They also are potential candidates for development of an S. neurona-specific immunoassay.
topes. Immunoblot analysis detected 8 proteins that
Immunoblot analysis of S. neurona merozoite antigens using the 3 rabbit antisera demonstrated many epitopes shared with S. cruzi and S. muris bradyzoites. Recognition of 6 of the 8 S. neurona-specific proteins by rabbit anti-S. neurona serum but not by rabbit anti-S. muris or S. cruzi sera supports the results obtained with equine sera.
Serum IFA titers did not provide clear differentiation between exposure to S. fayeri or S. neurona. Sarcocystis fayeri infection or S. neurona inoculation resulted in titers of only 50 and 25, respectively. Titers 
